Antitumor activity and molecular dynamics simulations of paclitaxel-laden triazine dendrimers

Molecular Pharmaceutics

Volumn 9, Issue 3, 2012, Pages 404-412

  Lim, Jongdoo ^a   Lo, Su Tang ^b   Hill, Sonia ^b   Pavan, Giovanni M ^c   Sun, Xiankai ^b   Simanek, Eric E ^a  

^a TEXAS CHRISTIAN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF APPLIED SCIENCES AND ARTS OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

dendrimer; drug delivery; molecular dynamics; paclitaxel; prostate cancer; simulation; triazine; xenografts

Indexed keywords

DENDRIMER; MACROGOL; PACLITAXEL; PRODRUG; TRIAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER REGRESSION; CONTROLLED STUDY; DRUG DOSE COMPARISON; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIMULATION; TREATMENT DURATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DENDRIMERS; HUMANS; MALE; MICE; MICE, NUDE; MICE, SCID; MOLECULAR DYNAMICS SIMULATION; PACLITAXEL; PROSTATIC NEOPLASMS; TRIAZINES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863229418     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp2005017     Document Type: Article

References (50)

1. Rowinsky, E. K. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents Annu. Rev. Med. 1997, 48, 353-374 (Pubitemid 27101837)
2. Scripture, C. D.; Figg, W. D.; Sparreboom, A. Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy Ther. Clin. Risk Manage. 2005, 1, 107-114
3. Crown, J.; O'Leary, M.; Ooi, W. S. Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience Oncologist 2004, 9, 24-32 (Pubitemid 38747840)
4. Kingston, D. G.; Newman, D. J. Taxoids: cancer-fighting compounds from nature Curr. Opin. Drug Discovery Dev. 2007, 10, 130-144 (Pubitemid 46438642)
5. Holton, R. A.; Biediger, R. J.; Boatman, P. D. Semisynthesis of Taxol and taxotere. In Taxol: science and applications; Suffness, M., Ed.; CRC Press: Boca Raton, 1995; pp 97-121.
6. Hennenfent, K. L.; Govindan, R. Novel formulations of taxanes: a review. Old wine in a new bottle? Ann. Oncol. 2006, 17, 735-749
7. Terwogt, J. M.; Nuijen, B.; Huinink, W. W.; Beijnen, J. H. Alternative formulations of paclitaxel Cancer Treat. Rev. 1997, 23, 87-95 (Pubitemid 27317514)
8. Liebmann, J.; Cook, J. A.; Mitchell, J. B. Cremophor EL solvent for paclitaxel, and toxicity Lancet 1993, 342, 1428
9. Malingré, M. M.; Schellens, J. H.; Van Tellingen, O.; Ouwehand, M.; Bardelmeijer, H. A.; Rosing, H.; Koopman, F. J.; Schot, M. E.; Ten Bokkel Huinink, W. W.; Beijnen, J. H. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients Br. J. Cancer 2001, 85, 1472-1477 (Pubitemid 34001576)
10. Sparreboom, A.; van Tellingen, O.; Nooijen, W. J.; Beijnen, J. H. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL Cancer Res. 1996, 56, 2112-2115 (Pubitemid 26119912)
11. Feng, Z.; Zhao, G.; Yu, L.; Gough, D.; Howell, S. B. Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane Cancer Chemother. Pharmacol. 2010, 65, 923-930
12. Meerum Terwogt, J. M.; ten Bokkel Huinink, W. W.; Schellens, J. H.; Schot, M.; Mandjes, I. A.; Zurlo, M. G.; Rocchetti, M.; Rosing, H.; Koopman, F. J.; Beijnen, J. H. Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel Anticancer Drugs 2001, 12, 315-323 (Pubitemid 32453436)
13. Zou, Y.; Fu, H.; Ghosh, S.; Farquhar, D.; Klostergaard, J. Antitumor activity of hydrophilic paclitaxel copolymer prodrug using locoregional delivery in human orthotopic nonsmall cell lung cancer xenograft models Clin. Cancer Res. 2004, 10, 7382-7391 (Pubitemid 39487728)
14. Etrych, T.; Sírová, M.; Starovoytova, L.; Ríhová, B.; Ulbrich, K. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release Mol. Pharmaceutics 2010, 7, 1015-1026
15. Sugahara, S.; Kajiki, M.; Kuriyama, H.; Kobayashi, T. R. Complete regression of xenografted human carcinomas by a paclitaxel-carboxymethyl dextran conjugate (AZ10992) J. Controlled Release 2007, 117, 40-50 (Pubitemid 46161869)
16. Galic, V. L.; Herzog, T. J.; Wright, J. D.; Lewin, S. N. Paclitaxel poliglumex for ovarian cancer Expert Opin. Invest. Drugs 2011, 20, 813-821
17. Dhanikula, A. B.; Singh, D. R.; Panchagnula, R. In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of paclitaxel: gel, film, prodrug, liposomes and micelles Curr. Drug Delivery 2005, 2, 35-44 (Pubitemid 40590919)
18. Dosio, F.; Reddy, L. H.; Ferrero, A.; Stella, B.; Cattel, L.; Couvreur, P. Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation Bioconjugate Chem. 2010, 21, 1349-1361
19. Boas, U.; Heegaard, P. M. H. Dendrimers in drug research Chem. Soc. Rev. 2004, 33, 43-63 (Pubitemid 38376610)
20. Duncan, R. The dawning era of polymer therapeutics Nat. Rev. Drug Discovery 2003, 2, 347-360 (Pubitemid 37361705)
21. Majoros, I. J.; Myc, A.; Thomas, T.; Mehta, C. B.; Baker, J. R. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality Biomacromolecules 2006, 7, 572-579
22. Lee, C. C.; MacKay, J. A.; Fréchet, J. M.; Szoka, F. C. Designing dendrimers for biological applications Nat. Biotechnol. 2005, 23, 1517-1526 (Pubitemid 41752929)
23. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 6, 6387-6392 (Pubitemid 17221789)
24. Maeda, H.; Matsumura, Y. EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy Adv. Drug Delivery Rev. 2011, 63, 129-130
25. Steffensen, M. B.; Simanek, E. E. Chemoselective building blocks for dendrimers from relative reactivity data Org. Lett. 2003, 5, 2359-2361 (Pubitemid 37161925)
26. Chouai, A.; Venditto, V. J.; Simanek, E. E.; Vanderplas, B. C.; Ragan, J. A. Large scale, green synthesis of a generation-1 melamine (triazine) dendrimer Org. Synth. 2009, 86, 151
27. Lim, J.; Mintzer, M. A.; Perez, L. M.; Simanek, E. E. Synthesis of odd generation triazine dendrimers using a divergent, macromonomer approach Org. Lett. 2010, 12, 1148-1151
28. Steffensen, M. B.; Simanek, E. E. Synthesis and manipulation of orthogonally protected dendrimers: building blocks for library synthesis Angew. Chem., Int. Ed. 2004, 43, 5178-5180 (Pubitemid 39382535)
29. Lim, J.; Chouai, A.; Lo, S. -T; Liu, W.; Sun, X.; Simanek, E. E. Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester/disulfide linkages Bioconjugate Chem. 2009, 20, 2154-2161
30. Holmes, F. A.; Walters, R. S.; Theriault, R. L.; Forman, A. D.; Newton, L. K.; Raber, M. N.; Buzdar, A. U.; Frye, D. K.; Hortobagyi, G. N. Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer J. Natl. Cancer Inst. 1991, 83, 1797-1805
31. Harper, E.; Dang, W.; Lapidus, R. G.; Garver, R. I., Jr. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice Clin. Cancer Res. 1999, 5, 4242-4248 (Pubitemid 30013811)
32. Seidman, A. D.; Tiersten, A.; Hudis, C.; Gollub, M.; Barrett, S.; Yao, T. J.; Lepore, J.; Gilewski, T.; Currie, V.; Crown, J. Phase II trial of paclitaxel by 3-h infusion as initial and salvage chemotherapy for metastatic breast cancer J. Clin. Oncol. 1995, 13, 2575-2581
33. Gradishar, W. J. Albumin-bound paclitaxel: a next-generation taxane Expert Opin. Pharmacother. 2006, 7, 1041-1053 (Pubitemid 43949942)
34. Desai, N.; Trieu, V.; Yao, Z.; Louie, L.; Ci, S.; Yang, A.; Tao, C.; De, T.; Beals, B.; Dykes, D.; Noker, P.; Yao, R.; Labao, E.; Hawkins, M.; Soon-Shiong, P. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel Clin. Cancer Res. 2006, 12, 1317-1324 (Pubitemid 43342524)
35. Lo, S. T.; Stern, S.; Clogston, J. D.; Zheng, J.; Adiseshaiah, P. P.; Dobrovolskaia, M.; Lim, J.; Patri, A. K.; Sun, X.; Simanek, E. E. Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct Mol. Pharmaceutics 2010, 7, 993-1006
36. Cheng, R.; Feng, F.; Meng, F.; Deng, C.; Feijen, J.; Zhong, Z. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery J. Controlled Release 2011, 152, 2-12
37. Pavan, G. M.; Mintzer, M. A.; Simanek, E. E.; Merkel, O. M.; Kissel, T.; Danani, A. Computational insights into the interactions between DNA and siRNA with "rigid" and "flexible" triazine dendrimers Biomacromolecules 2010, 11, 721-730
38. Shema-Mizrachi, M.; Pavan, G. M.; Levin, E.; Danani, A.; Lemchoff, N. G. Catalytic chameleon dendrimers J. Am. Chem. Soc. 2011, 133, 14359-14367
39. Merkel, O. M.; Zeng, M.; Mintzer, M. A.; Pavan, G. M.; Librizzi, D.; Maly, M.; Hoäffken, H.; Danani, A.; Simanek, E. E.; Kissel, T. Molecular modeling and in vivo imaging can identify successful flexible triazine dendrimer-based siRNA delivery systems J. Controlled Release 2011, 153, 23-33
40. Doni, D.; Kostiainen, M. A.; Danani, A.; Pavan, G. M. Generation-dependent molecular recognition controls self-assembly in supramolecular dendron-virus complexes Nano Lett. 2011, 11, 723-728
41. Pavan, G. M.; Kostiainen, M. A.; Danani, A. Computational approach for understanding the interactions of UV-degradable dendrons with DNA and siRNA J. Phys. Chem. B 2010, 114, 5686-5693
42. Case, D. A.; Darden, T. A.; Cheatham, T. E., III; Simmerling, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Walker, R. C.; Zhang, W.; Merz, K. M.; Robertson, B..; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Kolossvary, I.; Wong, K. F.; Paesani, F.; Vanicek, J.; Liu, J.; Wu, X.; Brozell, S.; Steinbrecher, T.; Gohlke, H.; Cai, Q.; Ye, X.; Wang, J.; Hsieh, M.-J.; Cui, G.; Roe, D. R.; Mathews, D. H.; Seetin, M. G.; Sangui, C.; Babin, V.; Luchko, T.; Gusarov, S.; Kovalenko, A.; Kollman, P. A. AMBER 11; University of California: San Francisco, 2010.
43. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water J. Chem. Phys. 1983, 79, 926-935
44. Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems J. Chem. Phys. 1993, 98, 10089-10092
45. Ryckaert, J. P.; Ciccotti, G.; Berendsen, H. J. C. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 1977, 23, 327-341
46. Krautler, V.; Van Gunsteren, W. F.; Hunenberger, P. H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations J. Comput. Chem. 2001, 22, 501-508 (Pubitemid 32291686)
47. Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules J. Am. Chem. Soc. 1995, 117, 5179-5197
48. Srinivasan, J.; Cheatham, T. E; Cieplak, P.; Kollman, P. A.; Case, D. A. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate - DNA helices J. Am. Chem. Soc. 1998, 120, 9401-9409 (Pubitemid 28452628)
49. Jayaram, B.; Sprous, D.; Beveridge, D. L. Solvation free energy of biomacromolecules: Parameters for a modified generalized Born model consistent with the AMBER force field J. Phys. Chem. B 1998, 102, 9571-9576 (Pubitemid 128611876)
50. Sitkoff, D.; Lockhart, D. J.; Sharp, K. A.; Honig, B. Calculation of electrostatic effects at the amino terminus of an alpha helix Biophys. J. 1994, 67, 2251-2260 (Pubitemid 24369647)